- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07518576
Development and Validation of Language and Communication Assessment Scales (SCALE_COM)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Sara Nordio, SLP,PhD
- Phone Number: 3494990310
- Email: sara.nordio@hsancamillo.it
Study Locations
-
-
VE
-
Venice, VE, Italy, 30126
- Recruiting
- IRCCS San Camillo
-
Contact:
- Sara Nordio
- Email: sara.nordio@hsancamillo.it
-
Principal Investigator:
- sara nrdio
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Patient admitted to the hospital for an intensive neurorehabilitation cycle or attending as an outpatient Diagnosis of language and communication disorders following a stroke in the right or left hemisphere Age > 18 years Ability to provide informed consent Native speaker of Italian (L1 Italian)
Exclusion Criteria:
- Unstable clinical conditions that may interfere with participation in the study (e.g., active symptomatic infections, stupor, need for oxygen therapy)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
person with aphasia
|
The conversational approach in speech-language rehabilitation focuses on improving communication within real-life, functional contexts.
It emphasizes natural, interactive communication, helping individuals engage in meaningful conversations and participate in daily activities.
Therapy often involves practicing communication in real-life scenarios, incorporating verbal and non-verbal cues.
The goal is to enhance confidence and effectiveness in communication, allowing individuals with speech or language difficulties to regain autonomy and engage more fully in social and professional settings.
Additionally, the assessment process is based on these principles and should also take place in conversation, evaluating communication skills within realistic, everyday contexts to better guide treatment planning.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Communicative efficacy
Time Frame: 36 months
|
Validity of the Communicative Efficacy Scale - Italian version: Content and construct validity assessed in aphasic patients; construct validity via correlation with established communication and gesture measures (correlation coefficients -1 to +1; closer to ±1 = stronger relationship). Reliability of the Communicative Efficacy Scale - Italian version: Inter- and intra-rater reliability evaluated using Intraclass Correlation Coefficient Communicative efficacy refers to the ability to effectively convey thoughts, needs, and emotions in a way that others can understand. It involves clarity, adaptability in communication methods, effective interaction, and achieving communicative goals. In speech-language rehabilitation, enhancing communicative efficacy focuses on improving a person's ability to participate in social, personal, and professional interactions despite language impairments, aiming to increase confidence and meaningful engagement in everyday communication. |
36 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022.02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Language Disorders
-
Purdue UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingDevelopmental Language Disorder and Language Impairment | Language Development | Specific Language ImpairmentUnited States
-
Heidelberg UniversityUnknownLanguage Delay | Developmental Language DisordersGermany
-
Purdue UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingLanguage Development | Developmental Language Disorder | Specific Language ImpairmentUnited States
-
Purdue UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedLanguage Development | Developmental Language Disorder | Specific Language ImpairmentUnited States
-
Université Catholique de LouvainNot yet recruitingUnderstanding the Predictive Factors and the Neurocognitive Basis of Developmental Language DisorderLanguage Development | Developmental Language DisordersBelgium
-
University College CorkNational University of Ireland, Galway, IrelandNot yet recruitingDevelopmental Language Disorder and Language Impairment | DeprivationIreland
-
Father Flanagan's Boys' HomeUniversity of Iowa; University of DelawareTerminatedSpecific Language ImpairmentUnited States
-
University of Sao PauloCompletedDevelopmental Language DisordersBrazil
-
University of HoustonNational Institute on Deafness and Other Communication Disorders (NIDCD); University...RecruitingDevelopmental Language Disorder | Language ImpairmentUnited States
-
University of HoustonNational Institute on Deafness and Other Communication Disorders (NIDCD); University...RecruitingDevelopmental Language Disorder | Language ImpairmentUnited States
Clinical Trials on conversational approach
-
University of NebraskaCompletedLoneliness | Pain, ChronicUnited States
-
Fondation Hôpital Saint-JosephRecruitingCardio Vascular DiseaseFrance
-
University of ArizonaRecruitingDevelopmental Language DisorderUnited States
-
Massachusetts General HospitalWayne State University; University of Michigan; National Institute on Aging (NIA) and other collaboratorsCompletedAging | Mild Cognitive ImpairmentUnited States
-
Centre Hospitalier Universitaire de la RéunionWithdrawn
-
Ain Shams UniversityCompletedDiabetes Mellitus, Type 1 | FastingEgypt
-
Boston Medical CenterNational Cancer Institute (NCI); Northeastern UniversityCompleted
-
Boston Medical CenterNational Cancer Institute (NCI); Northeastern UniversityTerminated
-
Northeastern UniversityBoston University; Tufts Medical CenterRecruiting
-
University of ArizonaCompleted